Marijuana - Companies & Stocks

[DarthYoda]

Bloomberg's Shea said that if the Democrats hold a majority in Congress after the midterms, progress toward legalization is a plausible scenario followed by "a subsequent rush of equity capital markets activity."

https://www.benzinga.com/analyst-ratings/analyst-color/22/10/29246460/heres-what-needs-to-happen-next-for-marijuana-stocks-to-uplist-on-major-us-exchange

[Zardiw]

#DDAmanda Chart on: $NWBO :

You can scan for these before they run. #DDAmanda works.

#DDAmanda Halloween Special: https://ddamanda.com/SignUpHalloween175.php



#DDAmanda is still the best way to find #WinningStocks before they run.
Contact/Text: 760 702-2009

Trial Subscription($8): https://www.ddamanda.com/SignUpDaily.php

What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.

Z

[FinlayS00]

Endexx Highlights Fiscal Fourth Quarter 2022 Accomplishments

$EDXC - Endexx Corporation reviews key accomplishments over the Company’s fiscal fourth quarter ahead of financial reporting.

Highlights include:

Blesswell™ men’s skincare line introduced first in Target stores and then on Amazon.com. Following Endexx’s CBD pain products availability at Walgreens and skincare at CVS , Endexx products are now available in four of the top eight retailers in the United States in over 8000 mass retail stores nationwide.

Amazon distribution of Blesswell™ skin care products expanded beyond the United States to 13 countries, including Australia, Belgium, Canada, France, Germany Italy, Japan, Mexico, Netherlands, Poland, Spain, Sweden, and the United Kingdom

Endexx significantly expanded its international distribution network and potential revenue streams though the controlling interest acquisition of HYLA, a non-nicotine, guarana-based vape product available in Germany, Italy, Israel, Egypt, Slovenia, Romania, Iran and Bahrain, the United States (where the HYLA formulations are produced) Canada, the Czech Republic, Georgia, Russia, Slovakia, South Africa, Switzerland, the United Arab Emirates, the United Kingdom, and Uzbekistan

Endexx strengthened its balance sheet by entering into the settlement, lock-up, and leak-out agreements with its Historic Investors, in which each Historic Investor agreed to exchange its pre-acquisition Convertible Note and Warrants with a replacement simple Promissory Note. This new Historic Investor Replacement Note removed the convertible debt and warrants and replaced by a simple, non-convertible debt facility with an 18-month term.

HYLA secured two new purchase orders exceeding 200,000 units in the first month of joining Endexx.

https://finance.yahoo.com/news/endexx-highlights-fiscal-fourth-quarter-120000947.html

[DarthYoda]

Historic cannabis news!...Major League Baseball and $CWBHF...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170173327
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170175588

[Martinell]

$OMID looking good today.

[BottomBounce]

Canopy Growth Corporation $CGC who's buying their stock shares? https://finance.yahoo.com/quote/CGC/holders?p=CGC

[BottomBounce]

Aurora Cannabis Inc. $ACB Who's buying? https://finance.yahoo.com/quote/ACB/holders?p=ACB

[BottomBounce]

Sundial Growers $SNDL whos buying? https://finance.yahoo.com/quote/SNDL/holders?p=SNDL

[BottomBounce]

Canopy Growth Corporation $CGC Top Institutional Holders
Holder Shares Date Reported % Out Value
Vanguard Group, Inc. (The) 8,099,679 Jun 29, 2022 1.69% 20,208,698
ETF Managers Group, LLC 7,856,049 Jun 29, 2022 1.64% 19,600,841
Millennium Management Llc 3,152,591 Jun 29, 2022 0.66% 7,865,714
Morgan Stanley 2,839,979 Jun 29, 2022 0.59% 7,085,747
Bank of America Corporation 2,057,707 Jun 29, 2022 0.43% 5,133,978
Two Sigma Investments, LP 1,862,092 Jun 29, 2022 0.39% 4,645,919
Bank of Montreal/Can/ 1,721,627 Jun 29, 2022 0.36% 4,295,459
Shaw D.E. & Co., Inc. 1,197,214 Jun 29, 2022 0.25% 2,987,048
Ameriprise Financial, Inc. 1,196,406 Jun 29, 2022 0.25% 2,985,032
Two Sigma Advisers, LP 1,157,100 Jun 29, 2022 0.24% 2,886,964
Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
ETF Managers Tr-EFTMG Alternative Harvest ETF 7,856,049 Jun 29, 2022 1.64% 19,600,841
Vanguard International Stock Index-Total Intl Stock Indx 3,249,463 Jul 30, 2022 0.68% 8,107,409
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 1,772,589 Jun 29, 2022 0.37% 4,422,609
Global X Fds-The Global X Cannabis ETF 1,543,348 Aug 30, 2022 0.32% 3,850,653
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 1,114,799 Jul 30, 2022 0.23% 2,781,423
Spinnaker ETF Tr-Cannabis ETF 489,767 May 30, 2022 0.10% 1,221,968
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF 469,798 Sep 29, 2022 0.10% 1,172,145
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 421,326 May 30, 2022 0.09% 1,051,208
Amplify Seymour Cannabis ETF 445,349 Jul 30, 2022 0.09% 1,111,145
DFA Investment Dimensions-Canadian Small Company Series 313,200 Jul 30, 2022 0.07% 781,433

[BottomBounce]

$ACB Top Institutional Holders
Holder Shares Date Reported % Out Value
ETF Managers Group, LLC 10,526,850 Jun 29, 2022 3.50% 10,947,923
Vanguard Group, Inc. (The) 7,118,236 Jun 29, 2022 2.37% 7,402,965
Millennium Management Llc 3,274,509 Jun 29, 2022 1.09% 3,405,489
Renaissance Technologies, LLC 3,220,384 Jun 29, 2022 1.07% 3,349,199
Shaw D.E. & Co., Inc. 2,664,650 Jun 29, 2022 0.89% 2,771,235
Two Sigma Investments, LP 2,515,071 Jun 29, 2022 0.84% 2,615,673
Morgan Stanley 2,385,461 Jun 29, 2022 0.79% 2,480,879
Mirae Asset Global Investments Co., Ltd. 1,798,034 Jun 29, 2022 0.60% 1,869,955
Bank of Montreal/Can/ 1,124,549 Jun 29, 2022 0.37% 1,169,530
Dimensional Fund Advisors LP 1,021,516 Jun 29, 2022 0.34% 1,062,376
Top Mutual Fund Holders
Holder Shares Date Reported % Out Value
ETF Managers Tr-EFTMG Alternative Harvest ETF 10,526,850 Jun 29, 2022 3.50% 10,947,923
Global X Fds-The Global X Cannabis ETF 2,921,758 Aug 30, 2022 0.97% 3,038,628
Vanguard International Stock Index-Total Intl Stock Indx 2,682,478 Jul 30, 2022 0.89% 2,789,777
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 1,563,747 Jun 29, 2022 0.52% 1,626,296
DFA Investment Dimensions-Canadian Small Company Series 763,275 Jul 30, 2022 0.25% 793,805
Spinnaker ETF Tr-Cannabis ETF 408,045 May 30, 2022 0.14% 424,366
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 351,932 May 30, 2022 0.12% 366,009
College Retirement Equities Fund-Stock Account 331,029 Jun 29, 2022 0.11% 344,270
Fidelity NASDAQ Composite Index Fund 266,465 Aug 30, 2022 0.09% 277,123
iShares Core MSCI Total International Stock ETF 252,412 Aug 30, 2022 0.08% 262,50

[DarthYoda]

For what it's worth, it is the Federal Government's own cannabis patent, 6630507, that lead many of us industry vets into the first "pot stocks" a decade ago. If they want rescheduling to move fast now, it will, as they really should have removed it from schedule 1 status as soon as they were assigned that patent. How long do we think it will take the Department of Health and Human Services to review their own patent LOL?...Expired or not, oddly enough, the patent was granted 19 years ago from today...

"Cannabinoids as antioxidants and neuroprotectants":

US-6630507-B1
Publication Date
2003/10/07
Current Assignee
US Department of Health and Human Services
Status
Expired - Lifetime

Abstract
Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula (I) wherein the R group is independently selected from the group consisting of H, CH3, and COCH3.

https://patents.google.com/patent/US6630507B1

U.S. Health and Human Services (HHS) Secretary Xavier Becerra said in Tampa Friday that he intends for his agency to move “as quickly as we can” to comply with President Joe Biden’s directive to review the decades-old policy of listing marijuana as a Schedule I drug.

https://www.marijuanamoment.net/biden-health-secretary-has-already-talked-to-fda-about-marijuana-scheduling-review-which-will-move-quickly/

[DarthYoda]

Actually..."Biden Health Secretary Has Already Talked To FDA About Marijuana Scheduling Review, Which Will Move ‘Quickly’":
October 7, 2022
https://www.marijuanamoment.net/biden-health-secretary-has-already-talked-to-fda-about-marijuana-scheduling-review-which-will-move-quickly/

[interloper]

Just great. So the MORE act will not be be passed anytime soon. They’re going to take their sweet ass time “investigating” why it is a schedule one drug. I can save them a bunch of time
but they already know this. It’s a schedule one because Mr. Rockefeller wanted it to be.

[DarthYoda]

"Justice Department Statement on President’s Announcements Regarding Simple Possession of Marijuana":
October 6, 2022

The Justice Department today released the following statement from spokesman Anthony Coley regarding the President’s proclamation granting a full, complete, and unconditional pardon to U.S. citizens and lawful permanent residents who have committed, or been convicted of, the offense of simple possession of marijuana in violation of the Controlled Substances Act, as currently codified at 21 U.S.C. 844 and as previously codified elsewhere in the U.S. Code, or in violation of D.C. Code 48–904.01(d)(1):

“The Justice Department will expeditiously administer the President’s proclamation, which pardons individuals who engaged in simple possession of marijuana, restoring political, civil, and other rights to those convicted of that offense. In coming days, the Office of the Pardon Attorney will begin implementing a process to provide impacted individuals with certificates of pardon.

“Also, in accordance with the President’s directive, Justice Department officials will work with our colleagues at the Department of Health and Human Services as they launch a scientific review of how marijuana is scheduled under federal law.”

https://www.justice.gov/opa/pr/justice-department-statement-president-s-announcements-regarding-simple-possession-marijuana

[DarthYoda]

Here buddy, "Pelosi Statement on President Biden’s Historic Marijuana Reform":
OCTOBER 6, 2022

San Francisco — Speaker Nancy Pelosi issued this statement after President Biden announced historic marijuana reform, including pardoning of previous federal offenses of simple possession and urging governors to do the same at the state level, and ordering a review of the classification of marijuana as Schedule I drug:

“Today is a day of hope and healing, as President Biden takes historic steps to reform America’s approach to marijuana. These transformative actions are the latest manifestation of Democrats’ unyielding commitment to justice, especially for those unfairly harmed by cannabis criminalization.

“For far too long, failed federal drug policies — which have specifically targeted communities of color — have torn apart too many families. By pardoning those arrested for simple marijuana possession, and encouraging governors to follow suit, President Biden is advancing racial and economic justice: empowering more Americans to return to their loved ones, find a good-paying job and contribute to our communities. At the same time, exploring the reclassification of marijuana is a necessary step to ensure that we do not repeat the grave mistake of mass incarceration.

“House Democrats applaud these bold actions by President Biden, which build on the important progress we forged in passing our Marijuana Opportunity Reinvestment and Expungement Act. This legislation, which decriminalizes marijuana at the federal level and empowers all to participate in the rapidly growing cannabis industry, must become law. Our proud Democratic Majority will never relent in fighting for these reforms, and more, as we work to advance justice for all.”

https://www.speaker.gov/newsroom/10622-0

[DarthYoda]

I don't know, but here are a handful of possible lines of reasoning that could be, and any combo of them...

1.)It's close to voting time, and the left hasn't been polling well, so this is one big tool for gaining back some support.

2.)Could be the MORE Act is just too difficult to get passed.

3.)It may just be time because, as you can see in my earlier post, based on what Obama said in 2015, having "enough" states decriminalized would allow congress to reschedule cannabis, and we now have more than fifty percent of the states decriminalized...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170114569

4.)Economic boost, why wait?

5.) Could just be getting too complicated with all the conflicting laws at the state and Federal levels.

I'm sure others can add more...

[interloper]

Why do you think he’s not using the MORE act?

[DarthYoda]

"Biden Announces Mass Marijuana Pardons And Calls For Cannabis Scheduling Review":
October 6, 2022

https://www.marijuanamoment.net/biden-announces-mass-marijuana-pardons-and-calls-for-cannabis-scheduling-review/

[DarthYoda]

Here comes the move to decriminalize...

"Biden to pardon all federal offenses of simple marijuana possession in first major steps toward decriminalization":
October 6, 2022
https://www.cnn.com/2022/10/06/politics/marijuana-decriminalization-white-house-joe-biden/index.html
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170114569

[DarthYoda]

A variety of sector news below...

This new paper below shows that CBD does not convert into THC in the stomach as some have suggested. This may be an important and positive finding for the industry...

"Will tetrahydrocannabinol be formed from cannabidiol in gastric fluid? An in vivo experiment":
2022 Oct 3

Abstract
Cannabidiol (CBD) products have ascribed an uprising trend for their health-promoting effects worldwide. In contrast to ?9-tetrahydrocannabinol (THC), CBD exhibits no state of euphoria. Since conversion of CBD into THC in an acidic environment has been reported, it has not been proved whether this degradation will also occur in human gastric fluid. A total of 9 subjects ingested 400 mg CBD as a water-soluble liquid together with lecithin as an emulsifier and ethanol as a solubilizer. Blood samples were taken up to 4 h, and urine samples were submitted up to 48 h. THC, 11-hydroxy-?9-THC (THC-OH), 11-nor-9-carboxy-?9-THC (THC-COOH), CBD, 7-hydroxy cannabidiol (7-OH-CBD), and 7-carboxy cannabidiol (7-CBD-COOH) were determined in blood and THC-COOH and 7-CBD-COOH in urine by LC-MS/MS. Neither THC, THC-OH, nor THC-COOH were detectable in any serum specimen. Only two urine samples revealed THC-COOH values slightly above the threshold of 10 ng/ml, which could also be caused by trace amounts of THC being present in the CBD liquid. It can be concluded that negative consequences for participants of a drug testing program due to a conversion of CBD into THC in human gastric fluid appear unlikely, especially considering a single intake of dosages of less than 400 mg. Nevertheless, there is a reasonable risk for consumers of CBD products being tested positive for THC or THC metabolites. However, this is probably not caused by CBD cyclization into THC in human gastric fluid but is most likely due to THC being present as an impurity of CBD products.

https://pubmed.ncbi.nlm.nih.gov/36190564/

"U.S. Cannabis: SAFE Plus Passage Is Possible In The Lame Duck, According To Cantor":
Oct 4, 2022
https://thedalesreport.com/cannabis/u-s-cannabis-safe-plus-passage-is-possible-in-the-lame-duck-according-to-cantor/

Reminder...FDA response requested by congress by 10/17...

"Griffith, Guthrie Call For Answers From FDA":
SEPTEMBER 19, 2022

Congressman Morgan Griffith (R-VA) and Congressman Brett Guthrie (R-KY) today sent two letters to Food and Drug Administration (FDA) Commissioner Dr. Robert Califf posing questions about numerous FDA regulatory lapses and calling for answers.

One of the letters focuses on FDA’s Center for Food Safety and Applied Nutrition (CFSAN) and its failures to ensure a safe and adequate infant formula supply. That letter can be viewed here.
https://morgangriffith.house.gov/uploadedfiles/cfsan_letter_9.19.22.pdf

The other letter focuses on lapses by CFSAN and the Center for Tobacco Products regarding cannabidiol (CBD), CBD-derived products, and tobacco products. That letter can be viewed here.
https://morgangriffith.house.gov/uploadedfiles/ctp_cfsan_letter_9.19.22.pdf

Responses to both letters are requested by October 17, 2022.

https://nrvnews.com/griffith-guthrie-call-for-answers-from-fda/

"Legalized marijuana market estimated to be worth $64 billion in US: Report":
October 6, 2022

A recent study by Coresight Research suggests that the marijuana market has nearly tripled over the previous three years as legalization spreads across the United States.

According to the report’s findings, 22% of the 1,017 survey participants from the 41 states (plus the District of Columbia) where marijuana is currently legal in some form reported having bought it for recreational or therapeutic purposes over the previous 12 months.

It also suggests that participants’ average monthly spending was $85; 1 in 4 spent less than $30, while 9% spent $200 or more.

As a result, Coresight projected that the market is now valued at around $64.3 billion yearly, up from $21.5 billion in 2019.

Two-thirds of marijuana users claimed that their use had grown since marijuana was legalized, 57% of those consumers claimed to have smoked it, 46% to have eaten it, and 42% to have vaped it.

https://minutemirror.com.pk/legalized-marijuana-market-estimated-to-be-worth-64-billion-in-us-report-65783/

Here is a podcast people can subscribe to from Jonathan Miller of U.S. Hemp Roundtable...
"Hemp Legally Speaking!":
https://www.hemplegallyspeakingpodcast.com/
https://www.hemplegallyspeakingpodcast.com/episodes

"Key congressional races the marijuana industry should watch":
October 5, 2022

Click below to learn about these races to watch:

U.S. Senate
https://www.nxtbook.com/emerald/MJBizMag/202210/index.php/44/?startid=44#/p/44
U.S. House of Representatives
https://www.nxtbook.com/emerald/MJBizMag/202210/index.php/44/?startid=48#/p/48

https://mjbizdaily.com/key-congressional-races-the-marijuana-industry-should-watch/

[DarthYoda]

Some cannabis industry news links below...

"2023 Farm Bill: Potential savior for hemp-derived cannabinoids?":
Oct 05, 2022
https://www.naturalproductsinsider.com/regulatory/2023-farm-bill-potential-savior-hemp-derived-cannabinoids

More coverage on new FDA cannabis regulator...

"FDA Hires Former New York & Rhode Island Cannabis Regulator as Senior Policy Advisor":
1 hour ago

In New York, Birenbaum helped oversee the implementation of rules that allowed CBD and other hemp-derived cannabinoid products to be sold as food, beverage, and dietary supplements.

https://www.ganjapreneur.com/fda-hires-former-new-york-rhode-island-cannabis-regulator-as-senior-policy-advisor/

"U.S. CBD stakeholders cheer appointment of cannabis expert at FDA":
OCTOBER 5, 2022
https://hemptoday.net/u-s-cbd-stakeholders-cheer-appointment-of-cannabis-expert-at-fda/

"The State of European Cannabis Reform: Fall 2022 Update":
October 5, 2022
https://www.cannabisbusinesstimes.com/article/state-european-cannabis-reform-fall-2022-update-marguerite-arnold/

More coverage of cannabinoid bioplastics...
"Cannabis Plastics In Medicine?":
October 5, 2022
https://hempgazette.com/news/cbd-plastic-medicine-hg1798/

"3 in 5 Voters Say Marijuana Should Be Legal Nationwide":
October 5, 2022

https://morningconsult.com/2022/10/05/most-voters-back-federal-marijuana-legalization/